YAP1 and cancer: While not having been tested in the treatment of cancer, flufenamic acid suppresses YAP-dependent transcription, cell proliferation and migration, therefore targeting the TEAD central pocket seems to be another solution in the treatment of tumors with dysregulated YAP/Hippo signaling [62,65].